Healthcare Triangle closes $6.5 million private placement

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list

Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.

Healthcare Triangle announces $6.5 million private placement

StimLabs announces new placental membrane-based product ‘Enverse’

The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems

Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement

Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery

Zydus receives final approval from USFDA for Lacosamide injection

Lacosamide Injection is used to treat partial-onset seizures.

Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant

Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients

Prolacta Bioscience appoints David Steinberg as CFO

Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA

SIMS Hospital conducts high-performance hip replacement surgery

The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition